Allena Pharmaceuticals, Inc. Income Tax Provision

Income Tax Provision of ALNA for past 10 years: annual, quarterly and twelve month trailing (TTM) including Income Tax Provision growth rates and interactive chart. The actual income tax expense for the applicable year.


Highlights and Quick Summary

Visit stockrow.com/ALNA for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Income Tax Provision of Allena Pharmaceuticals, Inc.

Most recent Income Tax Provisionof ALNA including historical data for past 10 years.

Interactive Chart of Income Tax Provision of Allena Pharmaceuticals, Inc.


Business Profile of Allena Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.